160 related articles for article (PubMed ID: 9010015)
1. Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson's disease patients at different levodopa plasma levels.
Kulisevsky J; Avila A; Barbanoj M; Antonijoan R; Berthier ML; Gironell A
Brain; 1996 Dec; 119 ( Pt 6)():2121-32. PubMed ID: 9010015
[TBL] [Abstract][Full Text] [Related]
2. 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa.
Gotham AM; Brown RG; Marsden CD
Brain; 1988 Apr; 111 ( Pt 2)():299-321. PubMed ID: 3378138
[TBL] [Abstract][Full Text] [Related]
3. Levodopa and executive performance in Parkinson's disease: a randomized study.
Pascual-Sedano B; Kulisevsky J; Barbanoj M; García-Sánchez C; Campolongo A; Gironell A; Pagonabarraga J; Gich I
J Int Neuropsychol Soc; 2008 Sep; 14(5):832-41. PubMed ID: 18764978
[TBL] [Abstract][Full Text] [Related]
4. Rasagiline for dysexecutive symptoms during wearing-off in Parkinson's disease: a pilot study.
Rinaldi D; Assogna F; Sforza M; Tagliente S; Pontieri FE
Neurol Sci; 2018 Jan; 39(1):141-143. PubMed ID: 28956175
[TBL] [Abstract][Full Text] [Related]
5. Paradoxical effect of dopamine medication on cognition in Parkinson's disease: relationship to side of motor onset.
Hanna-Pladdy B; Pahwa R; Lyons KE
J Int Neuropsychol Soc; 2015 Apr; 21(4):259-70. PubMed ID: 25923830
[TBL] [Abstract][Full Text] [Related]
6. Dopaminergic effects on cognitive performance in patients with Parkinson's disease.
Lange KW; Paul GM; Naumann M; Gsell W
J Neural Transm Suppl; 1995; 46():423-32. PubMed ID: 8821078
[TBL] [Abstract][Full Text] [Related]
7. Motor response to acute dopaminergic challenge with apomorphine and levodopa in Parkinson's disease: implications for the pathogenesis of the on-off phenomenon.
Colosimo C; Merello M; Hughes AJ; Sieradzan K; Lees AJ
J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):634-7. PubMed ID: 8648329
[TBL] [Abstract][Full Text] [Related]
8. The significance of continuous dopaminergic stimulation in the treatment of Parkinson's disease.
Chase TN
Drugs; 1998; 55 Suppl 1():1-9. PubMed ID: 9483164
[TBL] [Abstract][Full Text] [Related]
9. Dopamine supports sentence comprehension in Parkinson's Disease.
Grossman M; Glosser G; Kalmanson J; Morris J; Stern MB; Hurtig HI
J Neurol Sci; 2001 Mar; 184(2):123-30. PubMed ID: 11239945
[TBL] [Abstract][Full Text] [Related]
10. Effects of levodopa on cognitive functioning in moderate-to-severe Parkinson's disease (MSPD).
Morrison CE; Borod JC; Brin MF; Hälbig TD; Olanow CW
J Neural Transm (Vienna); 2004 Oct; 111(10-11):1333-41. PubMed ID: 15480842
[TBL] [Abstract][Full Text] [Related]
11. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
[TBL] [Abstract][Full Text] [Related]
12. Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levodopa requirements in fluctuating parkinsonian patients.
Baas H; Beiske AG; Ghika J; Jackson M; Oertel WH; Poewe W; Ransmayr G
J Neurol Neurosurg Psychiatry; 1997 Oct; 63(4):421-8. PubMed ID: 9343116
[TBL] [Abstract][Full Text] [Related]
13. Cognitive slowing in Parkinson's disease fails to respond to levodopa treatment: the 15-objects test.
Pillon B; Dubois B; Bonnet AM; Esteguy M; Guimaraes J; Vigouret JM; Lhermitte F; Agid Y
Neurology; 1989 Jun; 39(6):762-8. PubMed ID: 2725868
[TBL] [Abstract][Full Text] [Related]
14. Levodopa pharmacokinetic mechanisms and motor fluctuations in Parkinson's disease.
Fabbrini G; Juncos J; Mouradian MM; Serrati C; Chase TN
Ann Neurol; 1987 Apr; 21(4):370-6. PubMed ID: 3579222
[TBL] [Abstract][Full Text] [Related]
15. High-speed memory scanning in Parkinson's disease: adverse effects of levodopa.
Poewe W; Berger W; Benke T; Schelosky L
Ann Neurol; 1991 Jun; 29(6):670-3. PubMed ID: 1892368
[TBL] [Abstract][Full Text] [Related]
16. L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction.
Lange KW; Robbins TW; Marsden CD; James M; Owen AM; Paul GM
Psychopharmacology (Berl); 1992; 107(2-3):394-404. PubMed ID: 1615139
[TBL] [Abstract][Full Text] [Related]
17. Effects of Parkinson's disease and dopamine on digit span measures of working memory.
Grogan JP; Knight LE; Smith L; Irigoras Izagirre N; Howat A; Knight BE; Bickerton A; Isotalus HK; Coulthard EJ
Psychopharmacology (Berl); 2018 Dec; 235(12):3443-3450. PubMed ID: 30315362
[TBL] [Abstract][Full Text] [Related]
18. Performance of a motor task learned on levodopa deteriorates when subsequently practiced off.
Anderson ED; Horak FB; Lasarev MR; Nutt JG
Mov Disord; 2014 Jan; 29(1):54-60. PubMed ID: 24132873
[TBL] [Abstract][Full Text] [Related]
19. Motor fluctuations in Parkinson's disease: pathogenetic and therapeutic studies.
Mouradian MM; Juncos JL; Fabbrini G; Chase TN
Ann Neurol; 1987 Oct; 22(4):475-9. PubMed ID: 3435068
[TBL] [Abstract][Full Text] [Related]
20. Temporal relationships between plasma and cerebrospinal fluid pharmacokinetics of levodopa and clinical effect in Parkinson's disease.
Olanow CW; Gauger LL; Cedarbaum JM
Ann Neurol; 1991 May; 29(5):556-9. PubMed ID: 1859185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
